Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib

Fast Track application is based on positive data in NSCLC HER2 exon 20 insertion mutations in previously treated patients Positive Results for Cohort 2 of ZENITH20 clinical trial published in Journal of Clinical Oncology HENDERSON,...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news